Cite
HARVARD Citation
Dreesen, E. et al. (2023). A personalised taper-to-target strategy with adalimumab in Crohn's disease. Lancet gastroenterology and hepatology. pp. 293-294. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dreesen, E. et al. (2023). A personalised taper-to-target strategy with adalimumab in Crohn's disease. Lancet gastroenterology and hepatology. pp. 293-294. [Online].